Gastric Cancer. Overview.

Gastroenterology Clinics of North America

Volumn 42, Issue 2, 2013, Pages 211-217

  Correa, Pelayo ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Early detection; Epidemiology; Etiology; Gastric cancer; Helicobacter pylori; Host factors; Precancerous cascade; Prevention

Indexed keywords

ANTIBIOTIC AGENT;

BACTERIAL GENE; CAGA GENE; CANCER CLASSIFICATION; CANCER PREVENTION; CANCER SURGERY; DIET; DISEASE ASSOCIATION; DYSPEPSIA; EARLY CANCER; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; ERADICATION THERAPY; FRUIT; GENETIC POLYMORPHISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IL10 GENE; IL1B GENE; IL1RN GENE; NONHUMAN; PRECANCER; PREVALENCE; REVIEW; SALT INTAKE; STOMACH CANCER; TUMOR NECROSIS FACTOR ALPHA GENE; VEGETABLE;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS;

EID: 84877056233     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2013.01.002     Document Type: Review

References (27)

1. Ferlay J., Shin H.R., Bray F., et al. GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC CancerBase No. 10 2010, [Internet], International Agency for Research on Cancer, Lyon (France), Available at:, Accessed October 4, 2012. http://globocan.iarc.fr.
2. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
3. Miyahara R., Niwa Y., Matsuura T., et al. Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years. J Gastroenterol Hepatol 2007, 22:1435-1442.
4. Correa P., Cuello C., Duque E., et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976, 57:1027-1035.
5. Anderson W.F., Camargo M.C., Fraumeni J.F., et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 2010, 303:1723-1728.
6. IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. International Agency for Research on Cancer 1994, IARC Press, Lyon (France).
7. Schneider B.G., Peng D.F., Camargo M.C., et al. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer 2010, 127:2588-2597.
8. Censini S., Lange C., Xiang Z., et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996, 93:14648-14653.
9. Covacci A., Censini S., Bugnoli M., et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 1993, 90:5791-5795.
10. Higashi H., Tsutsumi R., Fujita A., et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A 2002, 99:14428-14433.
11. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol 2009, 44:239-248.
12. Cover T.L., Blanke S.R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005, 3:320-332.
13. Achtman M., Azuma T., Berg D.E., et al. Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol 1999, 32:459-470.
14. Falush D., Wirth T., Linz B., et al. Traces of human migrations in Helicobacter pylori populations. Science 2003, 299:1582-1585.
15. de Sablet T., Piazuelo M.B., Shaffer C.L., et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 2011, 60:1189-1195.
16. Murphy G., Pfeiffer R., Camargo M.C., et al. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009, 137:824-833.
17. IARC monographs on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking. International Agency for Research on Cancer 2004, IARC Press, Lyon (France).
18. Joossens J.V., Hill M.J., Elliott P., et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996, 25:494-504.
19. Gonzalez C.A., Jakszyn P., Pera G., et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006, 98:345-354.
20. Camargo M.C., Mera R., Correa P., et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1674-1687.
21. Loh M., Koh K.X., Yeo B.H., et al. Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 2009, 45:2562-2568.
22. Persson C., Canedo P., Machado J.C., et al. Polymorphisms in inflammatory response genes and their association with gastric cancer: a HuGE systematic review and meta-analyses. Am J Epidemiol 2011, 173:259-270.
23. AJCC cancer staging manual 2009, Springer-Verlag, New York. S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
24. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64:31-49.
25. Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011, 14:101-112.
26. WHO classification of tumours of the digestive system 2010, International Agency for Research on Cancer, Lyon (France). F.T. Bosman, F. Carneiro, R.H. Hruban (Eds.).
27. Correa P., Piazuelo M.B., Wilson K.T. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010, 105:493-498.